Table 1
Relative potency of antagonists
Antagonist
.
IC
50
, μM
.
Tetramer
.
ULC formation
.
Activation
.
PF4A01
20
59
33
PF4A17
ND
ND
ND
PF4A31-01
72
200
440
PF4A31-04
81
190
100
PF4A35
500
1300
500
Antagonist
.
IC
50
, μM
.
Tetramer
.
ULC formation
.
Activation
.
PF4A01
20
59
33
PF4A17
ND
ND
ND
PF4A31-01
72
200
440
PF4A31-04
81
190
100
PF4A35
500
1300
500
ND indicates not detectable.
View Large
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal